Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the Lung

NCT05470595 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT05470595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05470595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the Lung
Lead sponsor
Technische Universität Dresden
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 18, 2022
Completion date
January 31, 2029
Enrollment
67 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

large cell neuroendocrine carcinoma of the lung